HOME >> MEDICINE >> NEWS
Comparison of patients' access to new and better cancer drugs reveals inequalities between countries

er drugs with improved patient survival. Dr Wilking said: "Nearly half of the observed improvement in the two-year cancer survival rate between 1992 and 2000 at 50 USA cancer centres could be attributed to the use of newer cancer drugs. In 20 countries, including the USA and Europe, between 1995 and 2003, nearly a third of the reduction in cancer deaths could be accounted for by the use of newer drugs."

The authors called for action to end the inequalities. "It is our hope that this report will inspire policy makers and decision makers to take action to address these imbalances so that access to new innovative cancer drugs does not become dependent on the patient's country of residence," they said.

They pointed out that although cancer was second or third in terms of disease burden in most countries, the share of health care expenditure allocated to it was significantly lower than the share of the burden of the disease.

Dr Jnsson said: "Cancer accounts for about 5-6% of all health care expenditure and cancer drugs account for between 10-20% of this expenditure and just 5% of all drug costs. But cancer research continues to grow, with many new drugs and treatments expected to be introduced in the coming years. Countries need to address urgently how they are going to accommodate newer drugs into health care systems and pay for them."

Economic evaluation of new drugs and their cost effectiveness were becoming increasingly important, the authors said, with Europe and the UK in particular playing a leading role in the production of health technology assessments. In the UK these are produced by the National Institute for Health and Clinical Excellence (NICE). "It was the explicit objective at the establishment of NICE to avoid any significant delays to bringing innovations to market in the UK. There is yet no evidence that this objective is met," they report.

The report also highlights an imbalance in public investments
'"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
European Society for Medical Oncology
9-May-2007


Page: 1 2 3 4

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Comparison of 4 diet plans shows better outcomes for diet with lowest carbohydrate intake
3. Comparison of drug-releasing coronary stents show similar effectiveness
4. Hepatitis B patients understanding of infection and treatment deficient
5. Alzheimers weight gain initiative also improved patients intellectual abilities
6. Referral management schemes damage patients interests
7. Blood transfusions raise heart patients infection and death risk -- especially women
8. New UF tool measures heart implant patients anxiety
9. New research addresses taboos around the impact of rheumatoid arthritis on patients sex lives
10. Secret herb in tests to stop breast cancer patients hot flushes and night sweats
11. Internet research builds cancer patients confidence

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... ... Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) ... Action Award. , The Innovation to Action Award, a USAID Catalyst Award, ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American Board of ... watch for the discomforts and hidden dangers of foot fungus, particularly in the ... at risk for developing fungal infections on the feet or toenails, the Board ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the industry’s leading ... management services are delivered. Based on industry research and market feedback, the ...
(Date:9/19/2017)... Philadelphia, PA (PRWEB) , ... September 19, 2017 ... ... high-quality orthopedic dog beds, has been officially recognized for its September 2016 donation ... , The company recently received three awards and honors for its contribution ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... Del. , Sept. 6, 2017 NeuroRx, a ... Acute Suicidal Ideation and Behavior (ASIB), has been granted Fast ... its sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 ... in a pivotal trial of this sequential therapy targeting patients ... depression. 1 ...
(Date:9/5/2017)... has announced another milestone in their continued growth and success of the company.  ... of customer engagements regionally.  ... is located at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will ... In addition to ...
Breaking Medicine Technology:
Cached News: